InMed Pharmaceuticals Inc (INM) Cotización

Should see another big RS same time next year! They are experts at it.

INM: Results of their, "Pre-Clinical MODEL"???? (What an evasive PR!!! Was their study in MICE?? In mere Petri Dishes?? Or, merely in their COMPUTERS????)
https://www.stocktitan.net/news/INM/in-med-s-inm-901-demonstrates-statistically-significant-reduction-in-fn1p6qditmuf.html (PURE, WITCH-DOCTOREY BULLSHIT!!!)

Flip out $8.50s and be happy 

Great news $7.74 + 55%

INM.........................https://stockcharts.com/h-sc/ui?s=INM&p=W&b=5&g=0&id=p86431144783

Reverse split completed keep an eye $5.33 +'25%

Back to .25

Cool..................

Z

Getting some love PM

INM........................https://stockcharts.com/h-sc/ui?s=INM&p=W&b=5&g=0&id=p86431144783

They just don't run like they used to.......sigh...

Z

Thanks for the tip on this one Bill, took a little longer than I thought it would, better late than never. Chee, Chee, Chee

News!!

Vancouver, British Columbia--(Newsfile Corp. - August 21, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced it has been issued three U.S. patents: one for its formulation and method of use in the treatment of epidermolysis bullosa and related connective tissue disorders, one for biosynthesis manufacturing processes and one for an ocular drug delivery formulation.

The method of use patent, entitled "Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders" relates to INM-755 drug candidate which has completed a Phase 2 clinical trial in the treatment of symptoms related to epidermolysis bullosa. The patent has now been granted in the U.S., Australia, Japan and Israel and is pending in several other jurisdictions. The biosynthesis patent for the manufacturing of proprietary analogs for our drug development programs has been granted in U.S. Additionally, an ocular drug delivery formulation and use patent has been granted/allowed in the U.S., Europe, Australia, Japan, and India and is also pending in other jurisdictions.

As of August 20, 2024, InMed has a total of 13 patent families covering new chemical entities, formulations, manufacturing processes and methods of use. The Company continues to pursue new chemical entity patents on the drug candidates for both its INM-901 program in Alzheimer's disease and INM-089 in dry Age-related Macular Degeneration.

Summary of Granted Patents (to date):

Subject Matter
Scope
Status and jurisdiction
Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders
Method of Use
Granted: US, Australia, Japan, Israel

Pending: Several jurisdictions
Metabolic engineering of E. coli for the biosynthesis of cannabinoid products
Manufacturing Process
Granted: U.S. (will be issued on 9/3/24)

Pending: Several jurisdictions
Ocular drug delivery formulation
Formulation, Method of Use
Granted/Allowed: Australia, Japan, India, Europe, U.S.
Recombinant production systems for prenylated polyketides of the cannabinoid family
Manufacturing Process
Granted: U.S., Mexico

Pending: Several jurisdictions


InMed's President and CEO, Eric A. Adams, said "We are pleased to announce these U.S. patent issuances which help increase the commercial value of our programs and ensure the long-term protection of our drug research and development efforts. We are committed to continuing to build our patent portfolio to protect our novel drug candidates, methods of manufacturing these drugs, how they are formulated and how they are used to support the development of new treatments for diseases with high unmet medical needs."

Back to .31 already...wow.

$INM +191% - #DDAmanda Video Analysis - #1 Stock Scanner/Screener



Z

Hope pre market will be a repeat of this morning !

INM: Well then, NICE friend there, Fella!!! (Other than such NICE FRIENDS, below is what anybody's got in today's 'Wall Street' CASINO!!)


And the above BEAR figure --- at the end of the cartoon --- is very APROPOS to today's Markets!!!

Thank You...I was alerted by a friend to watch it when it was trading in the .2s so when it fell from mid .2s into teens I bought...but as you know it went ahead and fell down into the low teens...the only regret is that I didn't average/add down from my .1928 entry....still pretty happy with the return I did get.

INM: CONGRATS to yah, Home Boy!!! (LOVE-it!! Wish I had listened to Ms. Reena's alert!!! Did YOU simply get it on your OWN scanner???)

In at .1928...out at .7221
Anyone could have EASILY tripled their play in the Pre-M here

Nope! lol

INM: A purely PRE-MARKET play, if there ever was one!! WOW!! (I almost grabbed this puppy behind the "Reena969" alert early today, when this was up by 'only' 145%, but I didn't!! DAMN-IT!! Anyone could have EASILY tripled their play in the Pre-M here --- assuming a REASONABLE toss at it --- and otherwise LISTENING carefully when Ms. Reena posts something like, "INM is running".)

Welp….

maybe $+ soon

I’m in , going up from here !

nice

It ain’t done yet

Let’s join the scumbags!!!

Hell yes dude!!! These scumbags did the same with RNAZ

The automated wash trading scumbags have decided to manipulate this one today. Don't get trapped with grossly overpriced bags to hold.

80m plus traded since 8am….

All about float size +500% from there hedgies can manipulate floats and you join them

whats crazy is igc has similar type news but way bigger float but is red 🥵 https://healthstockshub.com/news/nyseamex/igc/igc-pharma-expands-drug-portfolio-to-metabolic-disorders-with-igc-1a-a-potential-new-glp-1-agonist

Almost 40m has traded in last 12 mins LOL

Look at these fraudsters

INM...................................................https://stockcharts.com/h-sc/ui?s=INM&p=W&b=5&g=0&id=p86431144783

This is legal LOL

INM: And yet ANOTHER (mere, useless) "Drug Candidate" news mill!!! (Why don't these scams simply invent a CURE for whatever disease they are exploiting???!!!!)

I can't believe this dropped like a stone right after I bought.
Terrible timing and terrible stock even for a micro

The chart looked good for a move past $0.30. The news was preclinical and market was not trading well Tuesday. I think they released the news 1 day too late. When the stock showed weakness trying to break $0.30 it just lost all stream and day traders exited the stock for the next play. Who knows? Maybe they used that ATM to get more money at the expense of shareholders. Either way, it sucked.

Me neither. I bet 80% of these small cap companies go down over time too. At least 80

I have never shorted a stock in my life and I often ask myself why am I a bull trader..the odds seem so much better being a bear.
I literally bought at the end of last week and BAM! I hate when this happens. I wish I never saw this ticker.

I literally bought at the end of last week and BAM! I hate when this happens. I wish I never saw this ticker.

Same. Might add here. Watching for the first hour probably.

I wasn't expecting a dip yesterday. May buy more. I bought because the cash position, not to mention balance sheet, is very good. Cash and Stockholder equity is more than the market cap. One of the four drug candidates is almost to phase III and three more coming. About as good a chance as you can have with a pharmy here. However, I'm down 16%. Go figure.

https://www.stocktitan.net/news/INM/in-med-pharmaceuticals-announces-favorable-behavioral-outcomes-with-skfsduulqfg5.html

INM........................................https://stockcharts.com/h-sc/ui?s=INM&p=W&b=5&g=0&id=p86431144783

News out. Really good news. Lots of resistance and selling at $0.30. Keep up the volume and break $0.30 and this should run to $0.40 at least. Just need volume. I like my chances here.
JMO.

However unlimited selling by OTCBB. Must be the recent financiers selling left and right.
Who knows.

Chart looks really good for a significant breakout past $0.30 which is also resistance upper trend line since November. Just needs some stimulus to get the ball rolling. Some of these low float stocks can make significant runs to $0.50 or even $1.00. Alzheimer’s treatment is hit right now. Strike while the iron is hot INM.

Chart looks good. Stock trying to break $0.30.
Alzheimer’s conference this week.
Maybe news. Maybe not.
I like the possibilities here. Not too many shares outstanding.
Hoping for a move to $0.35 to $0.40 in the next several weeks.
Have a Good trading week.